Celularity Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $922.00K.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $814.00K.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $272.00K.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $3.36M.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $922.00K, a 45.76% decline from fiscal 2024.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $1.70M, a 61.75% decline from fiscal 2023.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $4.44M, a 8.71% increase from fiscal 2022.
- Celularity Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $4.09M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $922.00K 10-K · filed 2026-04-30 | |
| 2025-06-30 | $922.00K 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $1.70M 10-K · filed 2026-04-30 | |
| 2023-12-31 | $4.44M 10-K · filed 2025-05-08 | |
| 2023-09-30 | $814.00K 10-Q · filed 2024-12-06 | |
| 2023-06-30 | $272.00K 10-Q · filed 2024-12-06 | |
| 2023-03-31 | $3.36M 10-Q · filed 2024-12-06 | |
| 2022-12-31 | $4.09M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |